Advertisement

Topics

An Inflammatory Deal: Bristol Commits Up To $2.3bn To Buy IFM Therapeutics

15:39 EDT 4 Aug 2017 | SCRIP

Most of the deal's value is in milestone fees, but at $300m up front Bristol is giving IFM's Series A...

      

Related Stories

 

Original Article: An Inflammatory Deal: Bristol Commits Up To $2.3bn To Buy IFM Therapeutics

NEXT ARTICLE

More From BioPortfolio on "An Inflammatory Deal: Bristol Commits Up To $2.3bn To Buy IFM Therapeutics"

Quick Search
Advertisement